Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cerebral Venous Sinus Thrombosis and Acute Myocardial Infarction in a Patient with PAI-1 4G/4G Homozygosity.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association - 1 Nov 2020

Chiu Daniel, Weinberger Jesse

Abstract excerpt

The plasminogen activator inhibitor-1 (PAI-1) 4G/4G homozygous genotype represents a genetic thrombophilia that has been associated with enhanced risk of arterial and venous thrombotic events. The optimal anticoagulation strategy for PAI-1 4G homozygous patients is unclear. Herein we present a case of a patient with PAI-1 4G/4G homozygosity who was placed on dabigatran after developing cerebral venous sinus...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anticoagulants
Share to Antithrombins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Substitution

Share to Hemostasis

Share to Heparin

Share to Plasminogen Activator Inhibitor 1

Share to Treatment Failure

Share to Warfarin

Source

Identifiers

PMID: 33066907
DOI: 10.1016/j.jstrokecerebrovasdis.2020.105250

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cerebral Venous Sinus Thrombosis and Acute Myocardial Infarction in a Patient with PAI-1 4G/4G Homozygosity.PMID 33066907Read ↗

A Case of Unexplained Cerebral Sinus Thrombosis in a 22-Year-Old Obese Caucasian Woman.Semantic proximity Read ↗

Plasminogen Activator Inhibitor-1 (PAI-1) Gene Polymorphisms Associated with Cardiovascular Risk Factors Involved in Cerebral Venous Sinus ThrombosisSemantic proximity Read ↗

Investigation of Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G promoter polymorphism in Indian venous thrombosis patients: A case-control study.Semantic proximity Read ↗

An unusual cause of cerebral venous sinus thrombosis: prothrombin G20210A gene mutation.Semantic proximity Read ↗

Dysfunctional fibrinolysis and cerebral venous thrombosis.Semantic proximity Read ↗

Genetic Testing in the Diagnosis and Treatment of Cerebral venous sinus thrombosis: A Case ReportSemantic proximity Read ↗

Cerebral Thrombosis: A Neurogenetic Approach.Semantic proximity Read ↗

Plasminogen activator inhibitor-1 4G allele in the 4G/5G promoter polymorphism increases the occurrence of cerebral ischemia after aneurysmal subarachnoid hemorrhage.Semantic proximity Read ↗

Intraventricular hemorrhage in a full-term neonate associated with sinus venous thrombosis and homozygosity for the plasminogen activator inhibitor-1 4G/4G polymorphism.Semantic proximity Read ↗

PAI-1 4G/5G polymorphism is associated with brain vessel reocclusion after successful fibrinolytic therapy in ischemic stroke patients.Semantic proximity Read ↗

Cerebral venous sinus thrombosis as a recurrent thrombotic event in a patient with heterozygous prothrombin G20210A genotype after discontinuation of oral anticoagulation therapy: how long should we treat these patients with warfarin?Semantic proximity Read ↗

Type I plasminogen activator inhibitor 4G allele frequency is associated with chronic venous insufficiency.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.